BIT 2.94% 3.3¢ biotron limited

On watch, page-36

  1. 425 Posts.
    lightbulb Created with Sketch. 115
    prove me wrong? In 2011 gilead bought out a small biotech company for $11B for a phase 2 Hep B antiviral. The company was the same size of Biotron.

    Bit is currently in phase two for a couple of compounds meaning it would be possible for a partnership. Possible

    now explain to me where I’m dreaming ? It may not be likely but it’s possible.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.3¢
Change
-0.001(2.94%)
Mkt cap ! $29.77M
Open High Low Value Volume
3.4¢ 3.5¢ 3.3¢ $8.412K 247.3K

Buyers (Bids)

No. Vol. Price($)
2 139827 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 76443 2
View Market Depth
Last trade - 15.43pm 17/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.